Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Ultrasonography in dermatology improves diagnosis and treatment of skin conditions.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Shikimic acid promotes hair growth.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Fat stem cells from diabetic mice can help heal skin wounds in other diabetic mice.